Reconstitution: The Basics Choosing Your Dilution The amount of bacteriostatic water you add determines the concentration of your solution: 250mg vial options: 2.5mL water = 100mg/mL (1mL = 100mg) 5mL water = 50mg/mL (1mL = 50mg) 10mL water = 25mg/mL (1mL = 25mg) Recommendation: For most research purposes, a 5mL dilution (50mg/mL) provides a good balance of manageable injection volumes and precise dosing
Below: injectable, IV, and buccal protocols with documented dose ranges, delivery-route trade-offs, and reconstitution math for the full mechanism and age-decline research, see the glutathione peptide page

The research literature differs in shape: AOD-9604 research base centers on the Metabolic Pharmaceuticals development program plus mechanism research on lipolytic activity Tesamorelin research base spans GHRH analog pharmacology plus the FDA-approved pharmaceutical clinical literature Application Comparison The mechanisms translate to different research applications: AOD-9604 research applications: Lipolytic mechanism research Fat metabolism studies Receptor-independent GH biology research Research on isolated lipolytic activity without IGF-1 effects Tesamorelin research applications: GHRH receptor pharmacology Pituitary GH axis research Multi-system effects of endogenous GH release (IGF-1 effects, downstream signaling) DPP-4-resistant peptide modification research These are different research applications with minimal overlap
Important Notice For Research Use Only (RUO)
Crohns disease, a form of inflammatory bowel disease (IBD), is a lifelong condition that results in inflammation and irritation of the digestive tract